Hyper-anxiety in early sobriety: psychopharmacological treatment strategies.
The importance of recognizing and treating anxiety disorders that co-occur with alcohol use disorders should not be underestimated, whether the anxiety is state (a transient condition) or trait (a chronic disorder). This article will discuss hyper-anxiety, a term the authors use to describe the uncomfortable, excessively anxious state that contributes to relapse. In addition, psychopharmacological strategies for relief of hyper-anxiety are suggested, and implications for recovery are discussed.
McGuinness
Teena M
TM
University of South Alabama, College of Nursing, Mobile, AL 36688-0002, USA. tmcguinness@usouthal.edu
Fogger
Susanne A
SA
D019973:Alcohol-Related Disorders / Q000150:complications*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001569:Benzodiazepines / Q000627:therapeutic use; D002065:Buspirone / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D024802:Nurse's Role; D009730:Nursing Assessment; D011568:Psychiatric Nursing; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000150:complications*; D001615:beta-Endorphin / Q000502:physiology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001569:Benzodiazepines; D001615:beta-Endorphin; D002065:Buspirone; D004298:Dopamine